Emerald Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Emerald Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-139,997	Closed	-$13M	–	303
2021 Q4	$13M	Sell	139,997 -233,701	-63%	-$15.4M	0.48%	81
2021 Q3	$22.3M	Buy	373,698 +49,562	+15%	+$2.93M	0.81%	53
2021 Q2	$22.1M	Sell	324,136 -2,971	-0.9%	-$194K	0.81%	46
2021 Q1	$22.7M	Sell	327,107 -37,285	-10%	-$2.87M	0.82%	48
2020 Q4	$28M	Buy	364,392 +248,747	+215%	+$18.6M	0.93%	39
2020 Q3	$8.65M	Buy	+115,645	New	+$7.71M	0.36%	94
2019 Q4	–	Sell	-287,899	Closed	-$13.2M	–	355
2019 Q3	$13.2M	Sell	287,899 -137,611	-32%	-$7.74M	0.62%	65
2019 Q2	$24.9M	Sell	425,510 -10,154	-2%	-$525K	1%	33
2019 Q1	$19.5M	Buy	435,664 +10,900	+3%	+$500K	0.79%	48
2018 Q4	$16.5M	Sell	424,764 -19,480	-4%	-$765K	0.81%	50
2018 Q3	$20.4M	Sell	444,244 -42,748	-9%	-$1.73M	0.75%	52
2018 Q2	$21.2M	Buy	486,992 +38,682	+9%	+$1.66M	0.8%	52
2018 Q1	$17.7M	Buy	+448,310	New	+$17.4M	0.71%	54

Emerald Advisers's ARNA Position: Q1 2022 in Review

Emerald Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 139,997 shares — an estimated $13M sold.

Emerald Advisers first reported a position in ARNA in Q1 2018 and held it in 13 quarters. The position peaked at $28M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Emerald Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Emerald Advisers sold 139,997 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $13M.
Emerald Advisers first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 13 quarters.
Emerald Advisers's Arena Pharmaceuticals Inc position peaked at $28M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.